|
0
|
|
Evaluation of teicoplanin concentrations for loading-dose optimization across BMI categories.
(academic.oup.com)
|
Kimura M
…
Koizumi Y
Journal of Antimicrobial Chemotherapy
2026-09-01
|
#pharmacokinetics
#dosing
#antibiotic
#therapeutics
|
|
0
|
|
Switching from etravirine to doravirine in people with HIV harbouring NNRTI resistance-associated mutations: the DorSwitch pilot study.
(academic.oup.com)
|
Sempere A
…
Blanco JL
Journal of Antimicrobial Chemotherapy
2026-09-01
|
#antibiotic
#hiv
#pharmacokinetics
#treatment-switching
|
|
0
|
|
IMPAACT 2041: Designing the Study of Glecaprevir/Pibrentasvir Treatment During Pregnancy.
(academic.oup.com)
|
Jhaveri R
…
Eke AC
Open Forum Infectious Diseases
2026-09-01
|
#pregnancy
#hepatitis c
#pharmacokinetics
#clinical trial
#antiviral
|
|
0
|
|
A prospective pharmacokinetic interaction study between rifampicin and fusidic acid for the treatment of staphylococcal infections.
(academic.oup.com)
|
Maggs C
…
Aboltins C
Journal of Antimicrobial Chemotherapy
2026-09-01
|
#pharmacokinetics
#drug-drug interaction
#staphylococcal
#infection
#amr
|
|
0
|
|
BV100 (rifabutin IV) drug interaction studies in healthy subjects with index CYP450 3A probes midazolam and itraconazole.
(academic.oup.com)
|
Delique P
…
Dale GE
Journal of Antimicrobial Chemotherapy
2026-09-01
|
#pharmacokinetics
#drug-drug interaction
#antibiotic
#cyp450
#infection
|
|
0
|
|
Oral KRAS G12D inhibitor GFH375 for previously treated advanced solid tumors with KRAS(G12D) mutations: a phase 1 trial.
(nature.com)
|
Ai X
…
Lu S
Nature Medicine
2026-09-01
|
#oncology
#kras
#clinical trial
#pharmacokinetics
#immunotherapy
|
|
0
|
|
Weight-based polymyxin B dosing for mortality and nephrotoxicity: an exploratory dose-response study.
(academic.oup.com)
|
Pan SC
…
Chuang YC
Journal of Antimicrobial Chemotherapy
2026-09-01
|
#antibiotic
#nephrotoxicity
#pharmacokinetics
#dosing
#amr
|